A systematic review article on the effects of FMT on obesity and MS including three randomized placebo-controlled studies with 76 patients reported that FMT improved peripheral insulin sensitivity in six weeks for patients receiving FMT compared to the placebo control. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.